Download FREE Report Sample
Download Free sampleA live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
Varicella Attenuated Live Vaccine Market contains market size and forecasts of Varicella Attenuated Live Vaccine in global, including the following market information:
Global Varicella Attenuated Live Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Varicella Attenuated Live Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Varicella Attenuated Live Vaccine companies in 2021 (%)
The global Varicella Attenuated Live Vaccine market was valued at 2627.5 million in 2021 and is projected to reach US$ 3484.5 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella Attenuated Live Vaccine include Merck, BCHT, Shanghai Institute, GSK, Keygen, Green Cross, Biken, Shanghai Rongsheng Biotech and Changchun Changsheng Life Sciences Limited. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Varicella Attenuated Live Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Attenuated Live Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Varicella Attenuated Live Vaccine Market Segment Percentages, by Type, 2021 (%)
Monovalent Vaccine
Combination Vaccine
Global Varicella Attenuated Live Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Varicella Attenuated Live Vaccine Market Segment Percentages, by Application, 2021 (%)
Kids Injection
Adults Injection
Global Varicella Attenuated Live Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Varicella Attenuated Live Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Attenuated Live Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Varicella Attenuated Live Vaccine revenues share in global market, 2021 (%)
Key companies Varicella Attenuated Live Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Varicella Attenuated Live Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
BCHT
Shanghai Institute
GSK
Keygen
Green Cross
Biken
Shanghai Rongsheng Biotech
Changchun Changsheng Life Sciences Limited
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
